New Results
A scaling law in CRISPR repertoire sizes arises from avoidance of autoimmunity
View ORCID ProfileHanrong Chen, View ORCID ProfileAndreas Mayer, Vijay Balasubramanian
doi: https://doi.org/10.1101/2021.01.04.425308
Hanrong Chen
1David Rittenhouse Laboratory, Department of Physics and Astronomy, University of Pennsylvania, USA
Andreas Mayer
2Lewis-Sigler Institute for Integrative Genomics, Princeton University, USA
Vijay Balasubramanian
1David Rittenhouse Laboratory, Department of Physics and Astronomy, University of Pennsylvania, USA
3Theoretische Natuurkunde, Vrije Universiteit Brussel, Belgium
Article usage
Posted January 04, 2021.
A scaling law in CRISPR repertoire sizes arises from avoidance of autoimmunity
Hanrong Chen, Andreas Mayer, Vijay Balasubramanian
bioRxiv 2021.01.04.425308; doi: https://doi.org/10.1101/2021.01.04.425308
Subject Area
Subject Areas
- Biochemistry (12917)
- Bioengineering (9822)
- Bioinformatics (31518)
- Biophysics (16247)
- Cancer Biology (13326)
- Cell Biology (19005)
- Clinical Trials (138)
- Developmental Biology (10302)
- Ecology (15308)
- Epidemiology (2067)
- Evolutionary Biology (19535)
- Genetics (12969)
- Genomics (17924)
- Immunology (13042)
- Microbiology (30465)
- Molecular Biology (12705)
- Neuroscience (66487)
- Paleontology (489)
- Pathology (2056)
- Pharmacology and Toxicology (3547)
- Physiology (5523)
- Plant Biology (11390)
- Synthetic Biology (3160)
- Systems Biology (7827)
- Zoology (1768)